News | Breast Imaging | June 12, 2017

Insignia Medical Systems, the pioneering, UK based, Enterprise Imaging provider, confirms a new contract with Avon Breast Screening (ABS)

ABS Clinical Director Alexandra Valencia, M.D.,  and consultant radiographer Gillian Clark using Insignia.

ABS Clinical Director Alexandra Valencia, M.D.,  and consultant radiographer Gillian Clark using Insignia.


ABS, one of the largest breast departments in the country, first signed with Insignia in 2010, and have confirmed a further 5 year managed service contract with PACS provider Insignia.

The Avon Breast Screening programme invites more than 140,000 women from the area for breast screening. A service which is coordinated through Avon Breast Screening, based in the Bristol Breast Care Centre at Southmead Hospital.

Supplying their InSight Mammo PACS solution, one of the leading Breast Care PACS in the UK with workflows specifically developed for screening, symptomatic and assessment, to the center.

Clare McLachlan, Acting Superintendent, Avon Breast Screening commented “We selected Insignia because they provide excellent support with regular updates. They are constantly improving their software to reflect new technologies such as tomosynthesis, and their software is easy to use facilitating film reading of mammograms.”

Certified to NBSS Level 2, InSight Mammo improves workflow for Consultants and helps speed up diagnosis. Support for multiple modalities including FFDM, MRI, Gamma Imaging and ultrasound enables the entire imaging record to be included in the advanced hanging protocols.

Tomosynthesis imaging is supported within InSight Mammo delivering the latest technology for the Radiologists and Clinicians.

With the continued contract in place, Insignia and ABS are in discussion with other local Trusts in regards to image sharing to provide joined up Breast Care across the region. 

For more information: http://www.insigniamedical.co.uk/


Related Content

News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
Subscribe Now